Status:
RECRUITING
Prospective Registration Of Patient Data and Quality of Life in Eye Melanoma Patients
Lead Sponsor:
Leiden University Medical Center
Conditions:
Uveal Melanoma
Eligibility:
All Genders
18+ years
Brief Summary
PROQEM is a prospective cohort study among patients diagnosed with uveal melanoma to assess quality of life before and in the first five years after treatment.
Detailed Description
PROQEM is a prospective observational cohort study wherein patients with uveal melanoma are registered at diagnosis and are requested to fill in an array of questionaires before treatment and at 3, 6,...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Clinical or pathological diagnosis of a melanoma of the choroid or ciliary body
- No signs of metastasis after staging procedures with at least an X-thorax, blood test and an ultrasound of the liver
- Treatment by brachytherapy, proton therapy or enucleation
Exclusion
- None
Key Trial Info
Start Date :
March 5 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2030
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05377957
Start Date
March 5 2019
End Date
September 1 2030
Last Update
March 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leiden University Medical Center
Leiden, South Holland, Netherlands, 2333ZA